Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
Authors:
- Chris WilliamsCWChris Williams
- John A GreenJGJohn A Green
- 23 October 2001
- reference entry
- Published by Wiley
- No. 4,p. CD002225
Abstract
Background The National Cancer Institute (USA) alert in February 1999 stated that concomitant chemoradiotherapy should be considered for all patients with cervical cancer, based on evidence from five randomized controlled trials. Objectives To review all known randomized clinical controlled trials (RCTs) comparing concomitant chemotherapy and radiation therapy with radiotherapy for locally advanced cervical cancer. Search methods We searched electronic databases, trials registers and reference lists of published trial reports and review articles were also searched. Selection criteria This review includes RCTs in cervical cancer comparing concomitant chemoradiation with radiotherapy. In the experimental arm, further adjuvant chemotherapy was allowable. Hydroxyurea was considered inactive and allowable. Trials using radiosensitisers or radioprotectors in the experimental arm were excluded. Data collection and analysis Two authors reviewed trials for inclusion and extracted data. For meta‐analyses of time‐to‐event outcomes (survival, progression‐free survival), a hazard ratio (HR) was extracted or estimated from trial reports, where possible. Only overall rates of local and distant recurrence were presented in many reports so only an odds ratios (OR) of recurrence rates could be calculated, which takes no account of time to recurrence or censoring. The HRs and ORs for individual trials were combined across all trials, using the fixed effect model. Few trials reported acute toxicity adequately. Data were therefore grouped and the number of toxic events was used to calculate a single OR for each site and grade. Late toxicity was rarely described so could only be reviewed qualitatively. Main results Nineteen trials (17 published, two unpublished) were identified including 4580 patients, although due to patient exclusion and differential reporting 62 ‐to 78% were available for the analyses. The review strongly suggests chemoradiation improves overall survival and progression free survival, whether or not platinum was used with absolute benefits of 12% and 16% respectively. There was, however, statistical heterogeneity for these outcomes There was some evidence that the effect was greater in trials including a high proportion of stage I and II patients. Chemoradiation also showed significant benefit for both local and distant recurrence. Haematological and gastrointestinal toxicity was significantly greater in the concomitant chemoradiation group. Details of late morbidity were sparse. Authors' conclusions Concomitant chemoradiation appears to improve overall survival and progression‐free survival in locally advanced cervical cancer. It also reduces local and distant recurrence suggesting concomitant chemotherapy may afford cytotoxic and sensitisation effects. Some acute toxicity is increased, but data on long term side effects were sparse.Keywords
This publication has 47 references indexed in Scilit:
- Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group StudyJournal of Clinical Oncology, 1999
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaNew England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Eine randomisierte Studie zur kombinierten Radiochemotherapie versus alleinigen Radiotherapie beim fortgeschrittenen ZervixkarzinomStrahlentherapie und Onkologie, 1998
- A Randomized Trial of Standard versus Partially Hyperfractionated Radiation with or without Concurrent 5-Fluorouracil in Locally Advanced Cervical CancerGynecologic Oncology, 1998
- A Randomized Trial of Concurrent Chemoradiotherapy versus Radiotherapy in Advanced Carcinoma of the Uterine CervixGynecologic Oncology, 1997
- Adjuvant Chemotherapy versus Chemotherapy plus Pelvic Irradiation for High-Risk Cervical Cancer Patients after Radical Hysterectomy and Pelvic Lymphadenectomy (RH-PLND): A Randomized Phase III TrialGynecologic Oncology, 1996
- Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancerGynecologic Oncology, 1989
- Potentiation of radiotherapy by Cis-dichlorodiammine platinum (II) in advanced cervical carcinomaGynecologic Oncology, 1986